We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $259M
1-Year Est. Return 63.6%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.3M
AUM Growth
+$8.27M
Cap. Flow
+$2.82M
Cap. Flow %
3.31%
Top 10 Hldgs %
56.78%
Holding
49
New
6
Increased
6
Reduced
23
Closed
1

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$2.33M
2
HES
Hess
HES
+$1.18M
3
CVS icon
CVS Health
CVS
+$1.09M
4
AAPL icon
Apple
AAPL
+$373K
5
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$306K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.29M
2
AGN
Allergan plc
AGN
+$650K
3
IP icon
International Paper
IP
+$283K
4
CMCSA icon
Comcast
CMCSA
+$251K
5
MOS icon
The Mosaic Company
MOS
+$250K

Sector Composition

Rank Sector Weight
1 Technology 19.75%
2 Healthcare 19.57%
3 Communication Services 11.87%
4 Materials 9.81%
5 Financials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
26
Walmart Inc
WMT
$871B
$488K 0.57%
15,000
– –
GOOG icon
27
Alphabet (Google) Class C
GOOG
$3.9T
$446K 0.52%
7,600
– –
WFC icon
28
Wells Fargo
WFC
$261B
$387K 0.45%
8,000
-500
-6% -$24.6K
ABBV icon
29
AbbVie
ABBV
$458B
$383K 0.45%
4,750
-2,500
-34% -$205K
BRK.B icon
30
Berkshire Hathaway Class B
BRK.B
$1.07T
$352K 0.41%
1,750
– –
VIG icon
31
Vanguard Dividend Appreciation ETF
VIG
$111B
$318K 0.37%
+2,900
New +$306K
IBM icon
32
IBM
IBM
$202B
$310K 0.36%
2,301
-105
-4% -$13.4K
EXPE icon
33
Expedia Group
EXPE
$31.2B
$299K 0.35%
+2,510
New +$305K
MRSH
34
Marsh
MRSH
$86.3B
$235K 0.28%
2,500
-500
-17% -$44.2K
ACIA
35
DELISTED
Acacia Communications Inc
ACIA
$199K 0.23%
3,475
-2,100
-38% -$100K
QVCGA
36
DELISTED
QVC Group Inc Series A
QVCGA
$161K 0.19%
+207
New +$200K
INTC icon
37
Intel
INTC
$466B
$159K 0.19%
2,955
-1,100
-27% -$55.8K
TRIP icon
38
TripAdvisor
TRIP
$1.59B
$151K 0.18%
+2,930
New +$161K
DVYE icon
39
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$145K 0.17%
+3,600
New +$146K
GG
40
DELISTED
Goldcorp Inc
GG
$137K 0.16%
12,000
– –
FLG
41
Flagstar Bank National Association
FLG
$5.77B
$93K 0.11%
+2,667
New +$91.8K
SLB icon
42
SLB Ltd
SLB
$77.8B
$87K 0.1%
2,000
– –
XOM icon
43
ExxonMobil
XOM
$651B
$87K 0.1%
1,075
-400
-27% -$30.5K
C.PRS
44
DELISTED
Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum
C.PRS
$65K 0.08%
2,500
– –
LUV icon
45
Southwest Airlines
LUV
$22.1B
$52K 0.06%
1,000
– –
MTSI icon
46
MACOM Technology Solutions
MTSI
$20.4B
$46K 0.05%
2,750
– –
MS icon
47
Morgan Stanley
MS
$337B
$17K 0.02%
400
– –
LDOS icon
48
Leidos
LDOS
$14.1B
$16K 0.02%
250
– –
GILD icon
49
Gilead Sciences
GILD
$161B
– –
-20,680
Closed -$1.29M
1
2

Similar funds

NAM
NewGen Asset Management Toronto, Ontario, Canada $259M AUM 140.76% 1-Year Est. Return
CCAM
Codex Capital Asset Management Dallas, Texas $259M AUM 32.71% 1-Year Est. Return
QP
Quartz Partners Saratoga Springs, New York $259M AUM 26.69% 1-Year Est. Return
PW
Potentia Wealth San Jose, California $259M AUM 19.98% 1-Year Est. Return
BFP
Beacon Financial Planning Hyannis, Massachusetts $258M AUM 16.1% 1-Year Est. Return
TC
Toews Corporation Northfield, New Jersey $259M AUM 5.15% 1-Year Est. Return
FC
Financial Council Towson, Maryland $259M AUM 21.02% 1-Year Est. Return
GWM
Glass Wealth Management San Antonio, Texas $258M AUM 56.87% 1-Year Est. Return

Colrain Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Colrain Capital held 49 positions worth $85.3M, up 11% from $77M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Colrain Capital deployed $2.82M of net new capital in Q1 2019, opening 6 new positions and adding to 6 existing holdings. Its largest new stake was Vanguard Dividend Appreciation ETF: 2,900 shares worth $318K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Allergan plc, an estimated $650K trimmed.

  • Colrain Capital's largest Q1 2019 buy was Vanguard Dividend Appreciation ETF: 2,900 shares worth $318K.
  • Colrain Capital added most to Cigna in Q1 2019, an estimated $2.33M increase.
  • Colrain Capital's biggest Q1 2019 reduction was Allergan plc, cutting an estimated $650K.
  • Colrain Capital fully exited Gilead Sciences in Q1 2019, selling an estimated $1.29M.
  • Colrain Capital's ten largest holdings make up 57% of its $85.3M portfolio in Q1 2019.
  • Colrain Capital opened 6 new positions and closed 1 in Q1 2019.
  • Colrain Capital's portfolio value rose 11% quarter-over-quarter to $85.3M.

Based on Colrain Capital's 13F filing for Q1 2019, filed 2 May 2019.